🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials

  2. TAK-418

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  3. TAK-491

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  4. TAK-510

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  5. TAK-671

    Takeda

    Coronavirus Disease

    phase 1 small molecule terminated

    1 trial

  6. TAK-781

    Takeda

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  7. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Healthy

    phase 1 small molecule completed

    1 trial

  8. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  9. TAK-831 Oral Suspension

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia, Cerebellar Ataxia

    phase 1 small molecule terminated

    1 trial

  10. TAK-831 Oral Tablet

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. TAK-831 T2

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. TAK-831 Tablet T2

    NEUROCRINE BIOSCIENCES INC

    Healthy

    phase 1 small molecule completed

    1 trial

  13. TAK-861, TAK-861, TAK-861

    Takeda

    Narcolepsy with Cataplexy (Narcolepsy Type 1)

    phase 1 small molecule active

    1 trial

  14. TAK-881

    Takeda

    Healthy Volunteers

    phase 1 mab completed

    3 trials

  15. TAK-915

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. TAK-915 suspension

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. TAK-931

    Takeda

    Nonhematologic Neoplasms, Advanced

    phase 1 small molecule completed

    1 trial

  18. TAK-931 PIC

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  19. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  20. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  21. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  22. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  24. TBA-7371

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources